| ACA | Anti-cardiolipin antibodies |
| ALT | Alanine aminotransferase |
| AP | Alkaline phosphatase |
| APS | Antiphospholipid syndrome |
| AT-III | Antithrombin III |
| BCLC | Barcelona Clinic Liver Cancer |
| CT | Computed tomography |
| EV | Esophageal varices |
| FV | factor V Leiden mutation |
| FVL | Factor V Leiden |
| HCC | Hepatocellular carcinoma |
| HE | Hepatic encephalopathy |
| HIV | Human immunodeficiency virus |
| INR | International normalized ratio |
| JAK2 | Janus Kinase 2 mutation |
| LA | Lupus anticoagulant |
| LMWH | Molecular-weight heparin |
| LT | Liver transplantation |
| MELD | Model for End-Stage Disease |
| MRI | Magnetic resonance imaging |
| MTHFR | Methylenetetrahydrofolate reductase TT677 genotype |
| PAI-1 | Plasminogen activator inhibitor type 1 |
| PNH | Paroxysmal nocturnal hemoglobinuria |
| PTHR | Prothrombin G20210A mutation |
| PV | Polycythemia vera |
| PVT | Portal vein thrombosis |
| RCT | Randomized control trial |
| SBP | Spontaneous bacterial peritonitis |
| SMV | Superior mesenteric vei |
| SV | Splenic vein |
| TIPS | Transjugular intrahepatic portosystemic shunt |
| UK | United Kingdom |
| US | Ultrasound |
| VB | Variceal bleeding |